Head and neck cancers are a heterogeneous collection of malignancies of the upper
aerodigestive tract, salivary glands and thyroid. In this Review, we primarily focus on the …

Abstract Treatment of locoregionally advanced head and neck squamous cell carcinoma
involves a multidisciplinary approach that combines surgery, radiotherapy, and systemic …

Head and neck cancer is the sixth most common cancer worldwide. Dihydroartemisinin
(DHA), a semi-synthetic derivative of artemisinin, exhibits a wide range of biological roles …

Reactive oxygen species (ROS) induction is an effective mechanism to kill cancer cells for
many chemotherapeutics, while resettled redox homeostasis induced by the anticancer …

Microvascular free flap reconstruction has remained the standard of care in reconstruction of
large tissue defects following ablative head and neck oncologic surgery, especially for bony …

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1
(PD-1) are inhibitory checkpoints that are commonly seen on activated T cells and have …

Background Despite recent advances in understanding the complex immunologic
dysfunction in the tumor microenvironment (TME), fewer than 20% of patients with head and …

Background. Cancer is a known risk factor for developing active tuberculosis. We
determined the incidence and relative risk of active tuberculosis in cancer patients …

Immune checkpoint inhibitors (ICBs) have revolutionized cancer treatment producing
remarkable and durable responses for a range of malignancies. However, the additional …

Objectives Evaluating the effectiveness of melatonin in prevention of radiation‐induced oral
mucositis. Material and methods A randomized controlled clinical study was conducted on …